Table 2 Clinical outcomes
Total cohort (n = 45) | p-value | ||||
|---|---|---|---|---|---|
Preoperative | Postoperative | ||||
Mean ± SD | (Range) | Mean ± SD | (Range) | ||
Surface area (mm2) | |||||
Platform stable, Eyes open (PsEo) | 152 ± 112 | (47 – 782) | 199 ± 180 | (56 – 1087) | 0.105 |
Platform stable, Eyes closed (PsEc) | 195 ± 115 | (34 – 603) | 214 ± 114 | (45 – 555) | 0.308 |
Platform unstable, Eyes open (PuEo) | 470 ± 246 | (103 – 1459) | 430 ± 166 | (212 – 844) | 0.547 |
Somatosensory ratio (PsEc / PsEo) | 1.43 ± 0.71 | (0.46 – 3.21) | 1.39 ± 0.78 | (0.27 – 3.74) | 0.967 |
Visual ratio (PuEo / PsEo) | 5.73 ± 4.13 | (0.95 – 14.72) | 3.07 ± 1.96 | (0.58 – 9.52) | 0.002 |
Lysholm score | 66.2 ± 18.9 | (19.0 – 97.0) | 83.6 ± 12.8 | (50.0 – 100.0) | 0.001 |
IKDC | 41.1 ± 11.4 | (17.0 – 65.5) | 56.8 ± 9.6 | (39.0 – 79.0) | < 0.001 |
KOOS | |||||
Symptoms | 69.2 ± 17.0 | (32.1 – 96.4) | 75.6 ± 12.2 | (42.9 – 92.9) | 0.098 |
Pain | 71.9 ± 15.2 | (33.3 – 94.4) | 83.2 ± 13.5 | (47.2 – 100.0) | < 0.001 |
ADL | 80.8 ± 16.1 | (44.1 – 100.0) | 92.8 ± 9.6 | (64.7 – 100.0) | < 0.001 |
Sports | 38.3 ± 22.5 | (0.0 – 85.0) | 68.6 ± 16.1 | (35.0 – 100.0) | < 0.001 |
QoL | 29.3 ± 20.4 | (0.0 – 87.5) | 57.8 ± 20.0 | (12.5 – 100.0) | < 0.001 |
Isokinetic tests | |||||
Extension deficit (%) | 17.2 ± 17.5 | (-12.6 – 82.9) | |||
Flexion deficit (%) | -4.8 ± 28.9 | (-54.3 – 65.9) | |||
Flexion/Extension (F/E) ratio | -0.8 ± 0.24 | (-2.06 – 0.47) | |||
Anteroposterior laxity | |||||
Absolute (ipsilateral, mm) | 5.2 ± 1.2 | (3 – 8) | |||
Differential (side-to-side difference, mm) | 0.7 ± 0.6 | (0 – 3) | |||